Invention Grant
- Patent Title: Compositions and methods for inhibiting expression of GSK-3 genes
- Patent Title (中): 抑制GSK-3基因表达的组成和方法
-
Application No.: US13615164Application Date: 2012-09-13
-
Publication No.: US09029525B2Publication Date: 2015-05-12
- Inventor: Dinah Wen-Yee Sah , Gregory Hinkle
- Applicant: Dinah Wen-Yee Sah , Gregory Hinkle
- Applicant Address: US MA Cambridge
- Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Fenwick & West LLP
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/11 ; C12N15/113
Abstract:
The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting Glycogen Synthase Kinase-3 (GSK-3), and methods of using the dsRNA to inhibit expression of GSK-3.
Public/Granted literature
- US20130012572A1 Compositions And Methods For Inhibiting Expression Of GSK-3 Genes Public/Granted day:2013-01-10
Information query
